期刊： CURRENT OPINION IN ONCOLOGY, 2021; 33 (4)
Purpose of review Cancer treatment options have developed rapidly in the past years. Targeted- and immune therapy have resulted in additional supporti......
期刊： CURRENT OPINION IN ONCOLOGY, 2021; 33 (3)
Purpose of review This review aims to highlight recent advances in prostate cancer tumor-immune microenvironment research and summarize the state-of-t......
期刊： CURRENT OPINION IN ONCOLOGY, 2021; 33 (1)
Purpose of review Despite the significant advances in EGFR-mutant nonsmall cell lung cancer (NSCLC), some challenges remain. One of the permanent and ......
期刊： CURRENT OPINION IN ONCOLOGY, 2021; 33 (1)
Purpose of review TKI therapy has shown excellent efficacy and favorable tolerability in patients with mutation-positive nonsmall cell lung cancer. Ho......
期刊： CURRENT OPINION IN ONCOLOGY, 2021; 33 (1)
Purpose of review To describe the current status of lung cancer in China, including incidence, prevention, molecular testing and treatment. Recent fin......
期刊： CURRENT OPINION IN ONCOLOGY, 2020; 32 (3)
Purpose of review We focus on the emerging data from randomized clinical trials for optimal integration of induction, concurrent, and/or adjuvant chem......
期刊： CURRENT OPINION IN ONCOLOGY, 2020; 32 (4)
Purpose of review Genetic aberrations resulting in tropomyosin receptor kinase (TRK) fusion proteins can drive oncogenesis and are postulated to occur......
期刊： CURRENT OPINION IN ONCOLOGY, 2019; 31 (2)
Purpose of review Childhood blastomas, unlike adult cancers, originate from developing organs in which molecular and cellular features exhibit differe......
期刊： CURRENT OPINION IN ONCOLOGY, 2022; 34 (1)
Purpose of review This review aims to introduce the resistance mechanisms to osimertinib, discuss the therapeutic strategies, and make clinical update......
期刊： CURRENT OPINION IN ONCOLOGY, 2022; 34 (1)
Purpose of review The resistance of immune checkpoint inhibitors (ICIs) has become an obstacle to further improve the survival of patients with advanc......
期刊： CURRENT OPINION IN ONCOLOGY, 2022; 34 (1)
Purpose of review In this article, we focus on the role of artificial intelligence in the management of lung cancer. We summarized commonly used algor......
期刊： CURRENT OPINION IN ONCOLOGY, 2022; 34 (1)
Purpose of review The unique structure made Kirsten rat sarcoma (KRAS) 'undruggable' for quite an extended period. The functional mechanism of this sm......
期刊： CURRENT OPINION IN ONCOLOGY, 2022; 34 (1)
Purpose of review In this article, we aimed to summarize the recent progress being made in treatment of small cell lung cancer (SCLC). Recent findings......
期刊： CURRENT OPINION IN ONCOLOGY, 2022; 34 (1)
Purpose of review Cancer cells evade immune surveillance partly due to the immunosuppressive features of the tumor microenvironment (TME). Currently a......
期刊： CURRENT OPINION IN ONCOLOGY, 2017; 29 (1)
Purpose of reviewProbiotics can be used as an adjuvant for cancer prevention or/and treatment through their abilities to modulate intestinal microbiot......
